Connective tissue disease (CTD) related interstitial lung disease (CTD-ILD) is one of the
leading causes of morbidity and mortality of CTD. Clinically, CTD-ILD is highly heterogenous …

Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic
diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis …

Objective To analyze the efficacy and safety of nintedanib in patients with fibrosing
autoimmune disease–related interstitial lung diseases (ILDs) with a progressive phenotype …

Background The primary analysis of the INBUILD trial showed that in subjects with
progressive fibrosing interstitial lung diseases (ILDs), nintedanib slowed the decline in …

Interstitial lung disease (ILD) is considered the most frequent and serious pulmonary
complication in primary Sjögren's syndrome (pSS), with the majority of the studies indicating …

Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1%
of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary …

Primary Sjogren syndrome (pSS) is a systemic autoimmune disease characterised by
lymphocytic infiltration of exocrine glands and by a number of systemic manifestations …

Interstitial lung disease (ILD) is a relatively frequent manifestation of systemic autoimmune
rheumatic disorders (SARDs), including systemic sclerosis (SSc), rheumatoid arthritis (RA) …

Introduction Acute exacerbation (AE) is a devastating complication of rheumatoid arthritis-
associated interstitial lung disease (RA-ILD) and leads to high mortality. This study aimed to …

Introduction: Interstitial lung disease (ILD) represents a frequent extra-articular manifestation
of rheumatoid arthritis (RA) deeply impacting both quality of life and overall prognosis. Areas …